News

Pharmabiz17h
Dogwood Therapeutics doses first fifty patients in ongoing Halneuron phase 2b CINP clinical trials
Dogwood Therapeutics doses first fifty patients in ongoing Halneuron phase 2b CINP clinical trials: Atlanta Saturday, August 9, 2025, 18:00 Hrs [IST] Dogwood Therapeutics Inc, a d ...
Pharmabiz18h
Kedrion Biopharma receives US FDA orphan drug designation for plasma-derived treatment for congenital aceruloplasminemia
Kedrion Biopharma receives US FDA orphan drug designation for plasma-derived treatment for congenital aceruloplasminemia: Forte Lee, New Jersey Saturday, August 9, 2025, 17:00 Hrs ...
Pharmabiz19h
ProteinQure gets US FDA and Health Canada regulatory clearances to begin phase I trial of PQ203 in US and Canada
ProteinQure gets US FDA and Health Canada regulatory clearances to begin phase I trial of PQ203 in US and Canada: Toronto Saturday, August 9, 2025, 16:00 Hrs [IST] ProteinQure, a ...
Pharmabiz20h
Cosmo Pharma & Takeda renew strategic manufacturing pact for global supply of oral treatment for ulcerative colitis
Cosmo Pharma & Takeda renew strategic manufacturing pact for global supply of oral treatment for ulcerative colitis: Dublin, Ireland Saturday, August 9, 2025, 15:00 Hrs [IST] Cosm ...
Pharmabiz21h
Professor Susan Hopkins appointed as the new chief executive officer of the UKHSA
The government has announced the appointment of Professor Susan Hopkins as the new chief executive officer (CEO) of the UK ...
Pharmabiz22h
Genmab announces positive results from phase 3 EPCORE FL-1 trial of epcoritamab in patients with relapsed follicular lymphoma
Copenhagen, Denmark Saturday, August 9, 2025, 13:00 Hrs [IST] ...
Pharmabiz23h
US FDA announces new FDA PreCheck programme to boost US drug manufacturing
US FDA announces new FDA PreCheck programme to boost US drug manufacturing: Silver Spring, Maryland Saturday, August 9, 2025, 12:00 Hrs [IST] The US Food and Drug Administration a ...